AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Leukemia · Severe Aplastic Anemia · Non-hodgkin Lymphoma · Hodgkin Lymphoma · Kostmann · Diamond Blackfan Anemia · Amegakaryocytic Thrombocytopenia · Sickle Cell Disease · Beta-Thalassemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

New York Medical College, Valhalla, New York, United States
Contact: Study coordinator (Mitchell S Cairo, MD) · mitchell_cairo@nymc.edu · 914-594-2150
Contact: Study coordinator (Lauren Harrison, MSN) · lauren_harrison@nymc.edu · 6172857844

Study leads

Mitchell S Cairo
Study Chair
New York Medical College

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Acute Myeloid Leukemia · Neutropenia · Anemia

Abroad (travel likely)RecruitingPHASE1

Wuhan, China

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

T-cell Acute Lymphoblastic Lymphoma · T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Houston, United States · Houston, United States

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

B-NHL · B-Non Hodgkin Lymphoma · Acute Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States